IL6 and breast cancer: To target IL-6, thereby blocking MDSC-mediated immunosuppression, cryo-thermal therapy combined with anti-IL-6 treatment was performed in mice bearing 4T1 breast cancer and Lewis lung cancer (Figure 2A,B and Figure S2), contributing to a significantly improved long-term survival rate compared to cryo-thermal therapy alone.